Tuesday, May 21, 2019 1:04:37 PM
See I don't get wrapped up in the 'cash on hand', future potential when a company is in this stage. Now now saying the market and some others aren't willing to pay $5/sh right now, but not me... There is one that I hold that was going for $9/sh a few years before the phase 3 even started.. I bought a bunch of it shortly after the ph 3 started for under 30 cents/sh. All those that paid much higher kept arguing that the market had it 'wrong' that it was worth more than 30 cents. Kept trying to tell them, it may be, but the market doesn't care what you think, for its at 30 cents...
Same here, with time, we will know where the market bottoms this one out.. IF it holds above $3, I will be surprised (for reasons that have nothing to do with cash on hand, what it might be worth after an interim readout on a phase 3)...
So we will see. Might be surprised, might be a lot more willing to pay $3+ than I anticipated, or a lot less than you did... Market will let us know..
But, at least this phase is closed out and we will see a low price determined... and I can then decide how I want to start participating again.. Just wished we have more clarity on the timelines for the PH 1 to complete, ph 2, etc. Cause I'm a thinking the ph 1 (and will it be a combined ph 1/2 trial??) will take 6 months minimum to run/data scrub...
and since its pretty much a 'yes or no' outcome, could they get away with just a ph 1/2 trial due to the need for what they are trying to do?
Recent ARMP News
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/04/2024 10:35:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 09:03:37 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/23/2024 09:17:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:55:39 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:55:01 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:54:48 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:54:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:54:25 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:53:36 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:53:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:53:27 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/15/2023 10:24:56 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/22/2023 11:17:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2023 12:00:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 11:30:59 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 11:15:29 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/03/2023 08:35:42 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/03/2023 08:34:24 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 07/24/2023 08:30:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2023 08:30:30 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 07/11/2023 12:27:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2023 12:15:48 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM